AUM$2.6M
Expense Ratio0.78%
NAV$7.38
Holdings1
InceptionJan 13, 2022
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
—Dividend Yield
—Expense Ratio
0.78%AUM
$2.6MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Issuer
- KellyETFs
- Category
- Healthcare
- Types
- GenomicsTechnology
- Inception Date
- Jan 13, 2022
- Description
- The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Similar ETFs
The Kelly CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund issued by KellyETFs that launched on Jan 13, 2022. It currently manages $2.6M in assets under management. The fund charges an expense ratio of 0.78%. The fund holds 1 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Cash&Other | Cash & Other | 100.00% | 2,583,264 | $2.6M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — | ||
| 1W | — | — | ||
| 1M | — | — | ||
| 3M | — | — | ||
| 6M | — | — | ||
| YTD | — | — | ||
| 1Y | — | — | ||
| 3Y | -20.82% | — | ||
| 5Y | -48.03% | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
—
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | XDNA | Healthcare(223 ETFs) | Genomics(11 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.78% | 0.60% | 0.61% |
| AUM | $2.6M | $1.24B | $204.5M |
| Dividend Yield | — | 2.75% | 39.63% |
| Avg Volume | — | 800.9K | 321.8K |
| Holdings | 1 | 171 | 55 |
| Performance | |||
| 1-Month Return | — | -4.57% | -5.15% |
| 6-Month Return | — | +4.90% | -0.75% |
| YTD Return | — | -1.70% | -5.70% |
| 1-Year Return | — | +15.18% | +10.97% |
Compare with Another ETF
Search for an ETF to compare with XDNA: